Estrone sulfonates as inhibitors of estrone sulfatase

Steroids

Volumn 62, Issue 4, 1997, Pages 346-350

  Howarth, Nicola M ^a,c   Purohit, Atul ^b   Reed, Michael J ^b   Potter, Barry V L ^a  

^a University of Bath   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

analog; estrone sulfatase; inhibitor; sulfonate

Indexed keywords

ESTROGEN; ESTRONE 3 (4 TOLUENE)SULFONATE; ESTRONE DERIVATIVE; ESTRONE SULFATE; SULFATASE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ESTROGEN SYNTHESIS;

CHROMATOGRAPHY, THIN LAYER; ENZYME INHIBITORS; ESTRONE; MAGNETIC RESONANCE SPECTROSCOPY; NAPHTHOLS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATASES; SULFONIC ACIDS;

DRYOBALANOPS;

EID: 0030999931     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00243-7     Document Type: Article

References (22)

1. James VHT, Reed MJ (1980). Steroid hormones and human cancer. Prog Cancer Res Ther 14:471-487.
2. Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A (1988). Growth regulatory and peptide production by human breast carcinoma cells. J Steroid Biochem 30:53-61.
3. Bonney RC, Reed MJ, Davidson K, Beranek PA, James VHT (1983). The relationship between 17β-hydroxysteroid dehydrogenase activity and estrogen concentrations in human breast tumors and in normal breast tissue. Clin Endocrinol 19:727-739.
4. Van Landeghem AAJ, Poortman J, Nabuurs M, Thijssen JHH (1985). Endogenous concentration and sub-cellular distribution of estrogens in normal and malignant breast tissue. Cancer Res 45: 2900-2906.
5. Vermeulen A, Deslypere JP, Pavidaens R, Leclercq G, Roy F, Henson JC (1986). Aromatase, 17β-hydroxysteroid dehydrogenase and intra-tissular sex hormone concentrations in cancerous and normal breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 26:515-525.
6. Santner SJ, Feil PD, Santen RJ (1984). In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59: 29-33.
7. James VHT, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ (1987). Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies. Steroids 50:269-279.
8. Noel CT, Reed MJ, Jacobs HS, James VHT (1981). The plasma concentration of estrone sulfate in postmenopausal women: Lack of diurnal variation, effect of ovariectomy, age, and weight. J Steroid Biochem 14:1101-1105.
9. Pasqualini J, Getty C, Nguyen B-L, Vella C (1989). Importance of oestrogen sulphates in breast cancer. J Steroid Biochem 34:155-163.
10. Santen RJ, Santner SJ, Davis B, Veldhius J, Samojlik E, Ruby E (1978). Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 47:1257-1265.
11. Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AM, Jeffcoate SL, Coombes RC (1987). Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: Optimization of therapeutic dose and route. Cancer Res 47:1957-1961.
12. Li P-K, Pillai R, Young BL, Bender WH, Martino DM, Lin F-T (1993). Synthesis and biochemical studies of estrone sulfatase inhibitors. Steroids 58:106-111.
13. Dibbelt L, Li P-K, Pillai R, Knuppen R (1994). Inhibition of human placental sterylsulfatase by synthetic analogs of estrone sulfate. J Steroid Biochem Mol Biol 50:261-266.
14. Li P-K, Pillai R, Dibbelt L (1995). Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids 60:299-306.
15. Duncan LJ, Purohit A, Howarth NM, Potter BVL, Reed MJ (1993). Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: A potential therapeutic agent in breast cancer. Cancer Res 53:298-303.
16. Howarth NM, Cooper G, Purohit A, Duncan LJ, Reed MJ, Potter BVL (1993). Phosphonates and thiophosphonates as sulfate surrogates: Synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Bioorg Med Chem Lett 3:313-318.
17. Howarth NM, Purohit A, Reed MJ, Potter BVL (1994). Estrone sulfamates: Potent inhibitors of estrone sulfatase with therapeutic potential. J Med Chem 37:219-221.
18. Purohit A, Williams GJ, Howarth NM, Potter BVL (1995). Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-sulfamate. Biochemistry 34:11,508-11,514.
19. Perrin DD, Armarego WLF (1988). Purification of Laboratory Chemicals. Pergamon, Oxford.
20. Still WC, Kahn M, Mitra A (1978). Rapid Chromatographic technique for preparative separations with moderate resolution. J Org Chem 43:2923-2925.
21. Woo LWL, Lightowler M, Purohit A, Reed MJ, Potter BVL (1996). Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism. J Steroid Biochem Mol Biol 57:79-88.
22. Baldwin JE, Barton DHR, Dainis I, Pereira JLC (1968). Photochemical transformations. Part XXIV. The synthesis of 18-hydroxyestrone. J Chem Soc (C):2283-2289.